International Committee Communications ICTH-Subcommittee on Clinical Trials Registry of Multicenter Clinical Trials Ninth Report-1987

Thromb Haemost 1988; 59(01): 107-119
DOI: 10.1055/s-0038-1646769

Review Article

Schattauer GmbH Stuttgart

J P Boissel

The Unité de Pharmacologie Clinique, Hôpital Neuro-Cardiologique, Lyon, France

References
1 Verstraete M. Registry of prospective clinical trials First report. Thrombos Diathes Haemorrh 1975; 33: 655-63
2 Verstraete M. Registry of prospective clinical trials Second report. Thromb Haemostas 1976; 36: 239-50
3 Verstraete M. Registry of prospective clinical trials Third report. Thromb Haemostas 1978; 39: 759-67
4 Verstraete M. Registrv of prospective clinical trials Fourth report. Thromb Haemostas 1980; 43: 176-81
5 Verstraete M. Registry of prospective clinical trials Fith report. Thromb Haemostas 1982; 48: 334-8
6 Verstraete M. Registry of prospective clinical trials Sixth report. Thromb Haemostas 1984; 51: 283-90
7 Boissel J-R. Registry of prospective clinical trials. Seventh report. Thromb Haemostas 1986; 55: 282-91
8 Boissel J-P. Registry of prospective clinical trials. Eighth report. Thromb Haemostas 1987; 57: 361-71
9 Boissel J-P, Leizorovicz A, Peyrieux J-C. Dose-effect Relationship Estimation for Thrombolytic Therapy in Acute Myocardial Infarction. Semin Thromb Haemostas 1987; 13: 181-5
10 Leizorovicz A, Boissel J-P. and the APSAC Research Group. A Randomised Placebo-Controlled Pilot Dose-Response Study with Anisoylated Plasminogen Streptokinase Activator Complex in Acute Coronary Occlusions. Drugs 1987; 33 (suppl 3) 133-7